Edwards Lifesciences Shares Outstanding 2011-2025 | EW
Edwards Lifesciences shares outstanding history from 2011 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Edwards Lifesciences shares outstanding for the quarter ending September 30, 2025 were 0.586B, a 2.07% decline year-over-year.
- Edwards Lifesciences 2024 shares outstanding were 0.599B, a 1.66% decline from 2023.
- Edwards Lifesciences 2023 shares outstanding were 0.609B, a 2.37% decline from 2022.
- Edwards Lifesciences 2022 shares outstanding were 0.624B, a 1.11% decline from 2021.
|
Edwards Lifesciences Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 599 |
| 2023 | 609 |
| 2022 | 624 |
| 2021 | 631 |
| 2020 | 632 |
| 2019 | 637 |
| 2018 | 641 |
| 2017 | 648 |
| 2016 | 653 |
| 2015 | 661 |
| 2014 | 651 |
| 2013 | 683 |
| 2012 | 710 |
| 2011 | 716 |
| 2010 | 715 |
|
Edwards Lifesciences Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-09-30 | 586 |
| 2025-06-30 | 588 |
| 2025-03-31 | 588 |
| 2024-12-31 | 599 |
| 2024-09-30 | 598 |
| 2024-06-30 | 604 |
| 2024-03-31 | 604 |
| 2023-12-31 | 609 |
| 2023-09-30 | 610 |
| 2023-06-30 | 610 |
| 2023-03-31 | 611 |
| 2022-12-31 | 624 |
| 2022-09-30 | 625 |
| 2022-06-30 | 627 |
| 2022-03-31 | 629 |
| 2021-12-31 | 631 |
| 2021-09-30 | 632 |
| 2021-06-30 | 630 |
| 2021-03-31 | 631 |
| 2020-12-31 | 632 |
| 2020-09-30 | 631 |
| 2020-06-30 | 620 |
| 2020-03-31 | 635 |
| 2019-12-31 | 637 |
| 2019-09-30 | 636 |
| 2019-06-30 | 636 |
| 2019-03-31 | 637 |
| 2018-12-31 | 641 |
| 2018-09-30 | 640 |
| 2018-06-30 | 642 |
| 2018-03-31 | 645 |
| 2017-12-31 | 648 |
| 2017-09-30 | 649 |
| 2017-06-30 | 647 |
| 2017-03-31 | 649 |
| 2016-12-31 | 653 |
| 2016-09-30 | 654 |
| 2016-06-30 | 652 |
| 2016-03-31 | 653 |
| 2015-12-31 | 661 |
| 2015-09-30 | 660 |
| 2015-06-30 | 660 |
| 2015-03-31 | 662 |
| 2014-12-31 | 651 |
| 2014-09-30 | 650 |
| 2014-06-30 | 644 |
| 2014-03-31 | 651 |
| 2013-12-31 | 683 |
| 2013-09-30 | 677 |
| 2013-06-30 | 688 |
| 2013-03-31 | 699 |
| 2012-12-31 | 710 |
| 2012-09-30 | 714 |
| 2012-06-30 | 710 |
| 2012-03-31 | 708 |
| 2011-12-31 | 716 |
| 2011-09-30 | 714 |
| 2011-06-30 | 720 |
| 2011-03-31 | 723 |
| 2010-12-31 | 715 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $48.327B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $211.550B | 25.14 |
| Intuitive Surgical (ISRG) | United States | $200.076B | 78.28 |
| IDEXX Laboratories (IDXX) | United States | $55.821B | 55.44 |
| Alcon (ALC) | Switzerland | $38.804B | 26.22 |
| IQVIA Holdings (IQV) | United States | $37.136B | 20.71 |
| Mettler-Toledo (MTD) | United States | $28.016B | 32.78 |
| DexCom (DXCM) | United States | $25.870B | 35.66 |
| STERIS (STE) | Ireland | $25.250B | 26.07 |
| Waters (WAT) | United States | $22.990B | 30.41 |
| Hologic (HOLX) | United States | $16.693B | 17.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.668B | 0.00 |
| Globus Medical (GMED) | United States | $11.834B | 24.84 |
| Penumbra (PEN) | United States | $11.245B | 79.10 |
| Masimo (MASI) | United States | $7.446B | 23.86 |
| Glaukos (GKOS) | United States | $6.138B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.848B | 18.58 |
| Teleflex (TFX) | United States | $5.801B | 9.24 |
| TransMedics (TMDX) | United States | $4.607B | 54.58 |
| Veracyte (VCYT) | United States | $3.466B | 39.49 |
| LivaNova (LIVN) | United Kingdom | $3.386B | 18.29 |
| Alphatec Holdings (ATEC) | United States | $3.071B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.509B | 11.78 |
| Elekta AB (EKTAY) | Sweden | $2.116B | 19.79 |
| Artivion (AORT) | United States | $2.049B | 94.02 |
| PROCEPT BioRobotics (PRCT) | United States | $1.956B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.758B | 15.35 |
| UFP Technologies (UFPT) | United States | $1.620B | 21.39 |
| AxoGen (AXGN) | United States | $1.412B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.386B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.277B | 0.00 |
| IRadimed (IRMD) | United States | $1.231B | 58.64 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.027B | 5.56 |
| Pulse Biosciences (PLSE) | United States | $0.928B | 0.00 |
| SiBone (SIBN) | United States | $0.824B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.734B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.637B | 37.01 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.621B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.542B | 0.00 |
| NeuroPace (NPCE) | United States | $0.542B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.528B | 10.54 |
| RxSight (RXST) | United States | $0.513B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.460B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.441B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.430B | 11.87 |
| ClearPoint Neuro (CLPT) | United States | $0.382B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.359B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.350B | 58.29 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.33 |
| Spectral Diagnostics (EDTXF) | Canada | $0.280B | 0.00 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.234B | 0.00 |
| CVRx (CVRX) | United States | $0.220B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.182B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.177B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.172B | 0.00 |
| Solana (HSDT) | United States | $0.169B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.165B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.135B | 0.00 |
| Accuray (ARAY) | United States | $0.112B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.103B | 0.00 |
| Hyperfine (HYPR) | United States | $0.102B | 0.00 |
| Neuronetics (STIM) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.087B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.054B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.016B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.91 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |